Location of Repository

Severity of cardiovascular disease and health-related quality of life in men with prostate cancer: a longitudinal analysis from CaPSURE

By Lonneke V. van de Poll-Franse, Natalia Sadetsky, Lorna Kwan and Mark S. Litwin
Topics: Article
Publisher: Springer Netherlands
OAI identifier: oai:pubmedcentral.nih.gov:2491436
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (2005). 30-day mortality and major complications after radical prostatectomy: Influence of age and comorbidity.
    2. (2007). Assessment of prognosis with the total illness burden index for prostate cancer: Aiding clinicians in treatment choice.
    3. (1998). Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
    4. (1996). Can comorbidity be measured by questionnaire rather than medical record review?
    5. (2006). Cancer survivorship: The interface of aging, comorbidity, and quality care.
    6. (2008). D’Amico,A.V.,Denham,J.W.,Crook.J.,et al.(2007).Influenceof androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.
    7. (1995). Development and testing of a new measure of case mix for use in office practice.
    8. (1999). Diabetes mellitus: A predictor for late radiation morbidity.
    9. (2005). Do patients consistently report comorbid conditions over time?: Results from the prostate cancer outcomes study.
    10. (2001). Factors associated with initial therapy for clinically localized prostate cancer: Prostate cancer outcomes study.
    11. (2006). Healthrelated quality of life for men with prostate cancer and diabetes: A longitudinal analysis from CaPSURE.
    12. (2006). Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: Data from CaPSURE.
    13. (2006). Impact of comorbidity on treatment and prognosis of prostate cancer patients: A population-based study.
    14. (2002). Initial treatment for prostate carcinoma in relation to comorbidity and symptoms.
    15. (2007). Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis.
    16. (2007). On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer.
    17. (2001). Perspectives on comorbidity and cancer in older patients: Approaches to expand the knowledge base.
    18. (2004). Predicting quality of life after radical prostatectomy: Results from CaPSURE.
    19. (2006). Program (www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER 17 Regs Limited-Use,
    20. (2007). Prostate Cancer. In
    21. (1999). Quantifying comorbidity in a disease-specific cohort: Adaptation of the total illness burden index to prostate cancer.
    22. (2007). SEER data submission, posted to the SEER web site,
    23. (1999). Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor.
    24. (2006). Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer.
    25. (1996). The CaPSURE database: A methodology for clinical practice and research in prostate cancer.
    26. (1998). The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure.
    27. (2003). Time course and predictors of symptoms after primary prostate cancer therapy.
    28. (2000). Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.